Osteoprotective effect of Phaseolus vulgaris L in ovariectomy-induced osteopenia in rats

Menopause

Volumn 16, Issue 3, 2009, Pages 589-596

  Shirke, Sarika S ^a   Jadhav, Sanket R ^a   Jagtap, Aarti G ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Genistein; Ovariectomized rat; Phaseolus vulgaris L; Phytoestrogens; Postmenopausal osteoporosis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; CALCIUM; ESTRADIOL; PHASEOLUS VULGARIS EXTRACT; PHOSPHORUS; PHYTOESTROGEN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACID PHOSPHATASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MINERAL; BONE STRENGTH; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; NONHUMAN; OSTEOPENIA; OVARIECTOMY; PHASEOLUS VULGARIS; PHOSPHATE BLOOD LEVEL; RAT; SCANNING ELECTRON MICROSCOPY; TIBIA; UTERUS WEIGHT;

ANIMALS; BONE DISEASES, METABOLIC; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PHASEOLUS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS;

EID: 67649873336     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31818e64c4     Document Type: Article

References (43)

1. Kanis JA. Estrogens, the menopause and osteoporosis. Bone 1996;19: 185S-190S.
2. Horcajada-Molteni MN, Crespy V, Coxam V, et al. Rutin inhibits ovariectomy-induced osteopenia in rats. J Bone Miner Res 2000;15: 2251-2258.
3. An J, Tzagarakis-Foster C, Scharschmidt TC, et al. Estrogen receptor β - selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 2001;276:17808-17814.
4. Setchell KDR, Lydeking-Olsen E. Dietary phytoestrogens and their effects on bone: evidence from in vitro and in vivo, human observational and dietary intervention studies. Am J Clin Nutr 2003;78(Suppl):593S-609S.
5. Cos P, Bruyne TD, Apers S, et al. Phytoestrogens: recent developments. Planta Med 2003;69:589-599.
6. Rishi RK. Phytoestrogens in health and illness. Ind J Pharmacol 2002;34:311-320.
7. Tham DM, Gardener CD, Haskell WL. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological and mechanistic evidence. J Clin Endocrinol Metab 1998;83:2223-2235.
8. Boue SM, Wiese TE, Nehls S. Evaluation of estrogenic effects of legume extracts containing phytoestrogens. J Agric Food Chem 2003; 51:2193-2199.
9. Duke JA, Bogenschutz-Godwin MJ, duCellier J, Duke PAK. Black bean, green bean, etc (Phaseolus vulgaris). In: Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press LLC, 2002:82-83.
10. Kopcewicz J. Estrogens in developing bean (Phaseolus vulgaris L) plants. Phytochemistry 2002;10:1423-1427.
11. Ram A, Prasad B, Chopra RN, Santapau FH, Krishnan MS, Krishnamurthi A. Phaseolus Linn. In: The Wealth of India - A Dictionary of Indian Raw Materials and Industrial Products - Raw Materials. Vol. VIII. Delhi, India: Director Council of Scientific and Industrial Research, 1969:8-13.
12. Soxhlet extractor. Available at: http://en.wikipedia.org/wiki/Soxhlet- extractor. Accessed March 19, 2008.
13. Khandelwal KR. Preliminary phytochemical screening. In: Practical Pharmacognosy Techniques and Experiments. Pune, India: Nirali Prakashan, 2004:149-156.
14. Singleton VL, Orthofer R, Lamuela-Raventos RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol 1999;99:152-178.
15. Wanforth HB, Flecknell PA. Specific surgical operations. In: Experimental and Surgical Technique in the Rat, 2nd ed. New York: Academic Press, 1992:203-312.
16. Yin J, Tezuka Y, Subehan, et al. In vivo anti-osteoporotic activity of isotaxiresinol, a lignan from wood of Taxuz yunnanesis. Phytomedicine 2006;13:37-42.
17. Ke HZ, Simmons HA, Pirie CM, et al. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Endocrinology 1995;136:2435-2441.
18. Wanforth HB, Flecknell PA. Method of obtaining body fluids. In: Experimental and Surgical Technique in the Rat, 2nd ed. New York: Academic Press, 1992:68-99.
19. Bessy OA, Lowry OH, Brock MJ. A method for the rapid determination of alkaline phosphatase with five cubic millimetres of serum. J Biol Chem 1946;164:321-329.
20. Godkar P. Enzymes. In: Textbook of Medical Laboratory Techniques. Mumbai, India: Bhalani Publishing House, 1994:149-167.
21. Connerty HV, Briggs AR. Determination of serum calcium by means of o-cresophthalein complexon. Am J Clin Pathol 1966;45:290-296.
22. Godkar P. Water and mineral metabolism. In: Textbook of Medical Laboratory Techniques. Mumbai, India: Bhalani Publishing House, 1994:233-251.
23. Lowry O, Rosebrough N, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
24. Changrani NR, Chonkar A, Adeghate E, et al. Effects of streptozotocin-induced type 1 diabetes mellitus on total protein concentrations and cation contents in the isolated pancreas, parotid, submandibular, and lacrimal glands of rats. Ann N Y Acad Sci 2006;1084:503-519.
25. Kalu DN, Hardin RR, Cockerhan R. Evaluation of the pathogenesis of skeletal changes in ovariectomized rats. Endocrinology 1984;115: 507-512.
26. Peng Z, Tuukkanen J, Zhang H. The mechanical strength of bone in different rat models of experimental osteoporosis. Bone 1994;15:523-532.
27. Pytlik M, Janiec W, Cegiela U, et al. Influence of α-eschin on the femoral bone strength in ovariectomized rats. Pol J Pharmacol 1999;51: 511-515.
28. Richterich R, Colombo JP. Bones. In: Clinical Chemistry - Theory, Practice and Interpretation. New York: John Wiley & Sons, 1981: 487-514.
29. Watts NB. Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999;45:1359-1368.
30. Keenan MJ, Hegsted M, Jones KL, et al. Comparison of bone density measurement techniques: DXA and Archimedes principal. J Bone Miner Res 1997;12:1903-1907.
31. Cai DJ, Zhao Y, Glasier J, et al. Comparative effect of soy protein, soy isoflavones and 17β-festradiol on bone metabolism in adult ovariectomized rats. J Bone Miner Res 2005;20:828-839.
32. Arjmandi BH, Hollis BW, Kalu DN. In vivo effect of 17β estradiol on intestinal calcium absorption in rats. Bone Miner 1994;26:181-189.
33. Reddy PN, Lakshmana M. Prevention of bone loss in calcium deficient ovariectomized rats by OST-6, a herbal preparation. J Ethnopharmacol 2003;84:259-264.
34. Fanti P, Monier-Faugere MC, Geng Z, et al. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 1998;8:274-281.
35. Turner RT, Riggs BL, Spelsberg TC. Skeletal effects of estrogen. Endocrinol Rev 1994;15:275-300.
36. Dempster DW, Shane E, Hobert W, et al. A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: qualitative observations in normal and osteoporotic subjects. J Bone Miner Res 1986;1:15-21.
37. Recker RR. Low bone mass may not be the only cause of skeletal fragility in osteoporosis. Proc Soc Exp Biol Med 1989;191: 272-274.
38. Dr. Dukes phytochemical and ethnobotanical databases. http://www.ars-grin.gov/cgi-bin/duke/farmacy2.pl. Accessed January 24, 2005.
39. Brynin R. Soy and its isoflavones: a review of their effects on bone density. Altern Med Rev 2002;7:317-327.
40. Lee YB, Lee HJ, Kim KS, et al. Evaluation of preventive effect of isoflavone extract on bone loss in ovariectomized rats. Biosci Biotech Biochem 2004;68:1040-1045.
41. Onoe Y, Miyaura C, Ohta H, et al. Expression of estrogen receptor A in rat bone. Endocrinology 1997;138:4509-4512.
42. Routledge EJ, White R, Parker MG, et al. Differential effects of xenoestrogens on co-activator recruitment by estrogen receptor (ER) α and ERß. J Biol Chem 2000;275:35986-35993.
43. Young RL, Kumar NS, Goldzieher JW. Management of menopause when estrogen cannot be used. Drugs 1990;40:220-230.